PubMed=9118971; DOI=10.1002/(SICI)1098-2280(1997)29:2<189::AID-EM10>3.0.CO;2-A
Galloway S.M., Sofuni T., Shelby M.D., Thilagar A.K., Kumaroo V., Kaur P., Gulati D., Putman D.L., Murli H., Marshall R., Tanaka N., Anderson B., Zeiger E., Ishidate M. Jr.
Multilaboratory comparison of in vitro tests for chromosome aberrations in CHO and CHL cells tested under the same protocols.
Environ. Mol. Mutagen. 29:189-207(1997)

PubMed=9393622; DOI=10.1016/S1383-5718(97)00114-9
Yamada T., Odawara K., Kishida F., Nakatsuka I., Yoshitake A.
Development of a novel CHL/IU cell line with an incorporated gpt shuttle vector for concurrent analysis of gene mutations and chromosome aberrations.
Mutat. Res. 393:295-306(1997)

PubMed=10320750; DOI=10.1016/S0027-5107(99)00077-9
Hu T., Miller C.M., Ridder G.M., Aardema M.J.
Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing.
Mutat. Res. 426:51-62(1999)

PubMed=27692294; DOI=10.1016/j.mrgentox.2016.08.001
Lorge E., Moore M.M., Clements J., O'Donovan M.R., Fellows M.D., Honma M., Kohara A., Galloway S.M., Armstrong M.J., Thybaud V., Gollapudi B.B., Aardema M.J., Tanir J.Y.
Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing.
Mutat. Res. Genet. Toxicol. Environ. Mutagen. 809:1-15(2016)